文献速递细菌感染、耐药与抗菌药物

抗菌治疗不精确性:基于结局的模型以闭合数据到行动的循环

Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop.
PubMed 文献 · Lancet Infect Dis · 2023-08-31

抗菌药物耐药上升威胁医疗、食品供应与社会,不适当抗菌治疗是驱动因素之一,但缺乏基于结局的损害度量阻碍了决策者与领导者制定适当且可持续的抗菌治疗框架。本文提出一种基于数学的、结局导向的抗菌治疗适当性度量,称为不精确性,并概述政策制定者与医疗领导者利用该指标实施更有效抗菌药物管理干预的框架。

要点

  • 提出不精确性作为基于结局的抗菌治疗适当性度量。
  • 框架依赖学习型抗菌系统、实施科学、人工智能及监管研发变革。
  • 目标为更具生态与组织可持续性的抗菌药物开发、监管与处方模式。

核心结论

  • 提出不精确性这一基于数学的、结局导向的抗菌治疗适当性度量,并概述政策制定者与医疗领导者利用该指标实施更有效抗菌药物管理干预的框架。

研究设计与样本

  • 本文为Personal View,提出一种基于数学的、结局导向的抗菌治疗适当性度量(不精确性),并概述政策制定者与医疗领导者使用该指标的框架。

主要发现

  • 抗菌药物耐药上升威胁医疗系统、食品供应链与社会,不适当抗菌治疗是驱动因素之一。
  • 缺乏基于结局的损害度量阻碍了政策制定者与领导者制定适当且可持续的抗菌治疗框架。

临床怎么用

  • 框架通过基于公众与从业者参与的学习型抗菌系统、扎实的实施科学、人工智能进展以及监管、研究与开发变革来实现。
  • 框架的结局是更具生态与组织可持续性的抗菌药物开发、监管与处方模式。
  • 文中讨论了基于人工智能增强的抗菌治疗不精确性度量在新型抗菌药物开发、政策与患者路径中的实践、伦理与监管考量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Health-care systems, food supply chains, and society in general are threatened by the inexorable rise of antimicrobial resistance. This threat is driven by many factors, one of which is inappropriate antimicrobial treatment. The ability of policy makers and leaders in health care, public health, regulatory agencies, and research and development to deliver frameworks for appropriate, sustainable antimicrobial treatment is hampered by a scarcity of tangible outcome-based measures of the damage it causes. In this Personal View, a mathematically grounded, outcome-based measure of antimicrobial treatment appropriateness, called imprecision, is proposed. We outline a framework for policy makers and health-care leaders to use this metric to deliver more effective antimicrobial stewardship interventions to future patient pathways. This will be achieved using learning antimicrobial systems built on public and practitioner engagement; solid implementation science; advances in artificial intelligence; and changes to regulation, research, and development. The outcomes of this framework would be more ecologically and organisationally sustainable patterns of antimicrobial development, regulation, and prescribing. We discuss practical, ethical, and regulatory considerations involved in the delivery of novel antimicrobial drug development, and policy and patient pathways built on artificial intelligence-augmented measures of antimicrobial treatment imprecision.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Howard A, Reza N, Aston S, et al. Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop. Lancet Infect Dis. 2023. PMID: 37660712. doi:10.1016/S1473-3099(23)00367-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。